SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BVP'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 3 / 3 | ASP A 148ARG A 143ILE A 65 | NoneNoneBVP A 500 ( 4.2A) | 0.90A | 1a4gB-1osnA:undetectable | 1a4gB-1osnA:20.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.03A | 1axwA-4xscA:36.4 | 1axwA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.69A | 1axwA-4xscA:36.4 | 1axwA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.79A | 1axwB-4xscA:36.5 | 1axwB-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AXW_B_MTXB733_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96TRP A 97LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.93A | 1axwB-4xscA:36.5 | 1axwB-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1B02_A_C2FA281_0 (PROTEIN (THYMIDYLATESYNTHASE)) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.83A | 1b02A-4xscA:31.4 | 1b02A-4xscA:34.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1B02_A_C2FA281_0 (PROTEIN (THYMIDYLATESYNTHASE)) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.95A | 1b02A-4xscA:31.4 | 1b02A-4xscA:34.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_A_D16A414_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 12 | PHE A 68GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.63A | 1hvyA-4xscA:40.7 | 1hvyA-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_A_D16A414_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68GLU A 75ILE A 96TRP A 97PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.75A | 1hvyA-4xscA:40.7 | 1hvyA-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.57A | 1hvyB-4xscA:40.8 | 1hvyB-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_B_D16B415_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.68A | 1hvyB-4xscA:40.8 | 1hvyB-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 11 | PHE A 68GLU A 75ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.49A | 1hvyC-4xscA:40.7 | 1hvyC-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 11 | PHE A 68GLU A 75ILE A 96TRP A 97GLY A 210PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.71A | 1hvyC-4xscA:40.7 | 1hvyC-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 11 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.60A | 1hvyC-4xscA:40.7 | 1hvyC-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.53A | 1hvyD-4xscA:40.7 | 1hvyD-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 75ILE A 96LEU A 180LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.74A | 1hvyD-4xscA:40.7 | 1hvyD-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HVY_D_D16D417_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180PHE A 213 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)1PE A1002 (-3.8A) | 0.74A | 1hvyD-4xscA:40.7 | 1hvyD-4xscA:64.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 9 | PHE A 68GLU A 75ILE A 96TRP A 97ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.54A | 1i00A-4xscA:40.6 | 1i00A-4xscA:64.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 9 | PHE A 68TRP A 97ASP A 206LEU A 209GLY A 210TYR A 246 | None1PE A1002 (-4.7A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.78A | 1i00A-4xscA:40.6 | 1i00A-4xscA:64.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 9 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.43A | 1i00B-4xscA:24.2 | 1i00B-4xscA:64.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 9 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.67A | 1i00B-4xscA:24.2 | 1i00B-4xscA:64.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.91A | 1ju6A-4xscA:40.0 | 1ju6A-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.53A | 1ju6A-4xscA:40.0 | 1ju6A-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | PHE A 68ILE A 96TRP A 97GLY A 210PHE A 213 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)1PE A1002 (-3.8A) | 1.10A | 1ju6A-4xscA:40.0 | 1ju6A-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 9 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.55A | 1ju6B-4xscA:40.0 | 1ju6B-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.89A | 1ju6C-4xscA:40.0 | 1ju6C-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.54A | 1ju6C-4xscA:40.0 | 1ju6C-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.54A | 1ju6D-4xscA:40.0 | 1ju6D-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JU6_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | PHE A 68ILE A 96TRP A 97GLY A 210TYR A 246 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.89A | 1ju6D-4xscA:40.0 | 1ju6D-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.97A | 1jujA-4xscA:39.0 | 1jujA-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_A_LYAA315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.49A | 1jujA-4xscA:39.0 | 1jujA-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.97A | 1jujB-4xscA:39.0 | 1jujB-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_B_LYAB315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.50A | 1jujB-4xscA:39.0 | 1jujB-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.97A | 1jujC-4xscA:39.0 | 1jujC-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_C_LYAC315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.49A | 1jujC-4xscA:39.0 | 1jujC-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.97A | 1jujD-4xscA:39.0 | 1jujD-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JUJ_D_LYAD315_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.49A | 1jujD-4xscA:39.0 | 1jujD-4xscA:65.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_A_GA2A1_1 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 6 / 11 | GLU A 48ILE A 65TYR A 66GLN A 90ARG A 130ARG A 143 | BVP A 500 (-2.5A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)None | 0.88A | 1ki2A-1osnA:34.7 | 1ki2A-1osnA:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI2_B_GA2B2_1 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 48TRP A 53ILE A 65TYR A 66GLN A 90ARG A 130ARG A 143 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)None | 0.81A | 1ki2B-1osnA:34.9 | 1ki2B-1osnA:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_A_PE2A1_1 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 48TRP A 53ILE A 62ILE A 65TYR A 66GLN A 90ARG A 143 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.5A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)None | 0.96A | 1ki3A-1osnA:34.4 | 1ki3A-1osnA:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI3_B_PE2B2_1 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 48TRP A 53ILE A 62ILE A 65TYR A 66GLN A 90ARG A 143 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.5A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)None | 0.84A | 1ki3B-1osnA:35.1 | 1ki3B-1osnA:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_A_ID2A1_0 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 48TRP A 53ILE A 62ILE A 65TYR A 66GLN A 90 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.5A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A) | 0.64A | 1ki7A-1osnA:34.3 | 1ki7A-1osnA:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53ILE A 62ILE A 65ARG A 130 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.5A)BVP A 500 ( 4.2A)BVP A 500 (-2.8A) | 0.79A | 1ki7B-1osnA:35.1 | 1ki7B-1osnA:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KI7_B_ID2B2_0 (THYMIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53ILE A 65GLN A 90ARG A 130 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 ( 4.2A)BVP A 500 (-3.0A)BVP A 500 (-2.8A) | 0.61A | 1ki7B-1osnA:35.1 | 1ki7B-1osnA:31.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZR_B_CDXB901_1 (DNA TOPOISOMERASE II) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 7 | THR A 239ASN A 214TYR A 218LEU A 236 | NoneBVP A1001 (-2.8A)NoneNone | 1.09A | 1qzrA-4xscA:undetectable | 1qzrA-4xscA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZR_B_CDXB901_2 (DNA TOPOISOMERASE II) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 7 | THR A 239ASN A 214TYR A 218LEU A 236 | NoneBVP A1001 (-2.8A)NoneNone | 1.03A | 1qzrB-4xscA:undetectable | 1qzrB-4xscA:20.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 8 | ASP A 206LEU A 209GLY A 210TYR A 246 | NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.71A | 1rtsA-4xscA:40.9 | 1rtsA-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 8 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.48A | 1rtsA-4xscA:40.9 | 1rtsA-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RTS_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 7 | ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.51A | 1rtsB-4xscA:40.7 | 1rtsB-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.12A | 1tlsA-4xscA:36.3 | 1tlsA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.81A | 1tlsA-4xscA:36.3 | 1tlsA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.08A | 1tlsB-4xscA:36.5 | 1tlsB-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.72A | 1tlsB-4xscA:36.5 | 1tlsB-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96TRP A 97LEU A 180GLY A 210PHE A 213 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A) | 1.05A | 1tlsB-4xscA:36.5 | 1tlsB-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.07A | 1tsnA-4xscA:36.4 | 1tsnA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.74A | 1tsnA-4xscA:36.4 | 1tsnA-4xscA:40.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_B_AZZB1211_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ALA A 134PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.9A)BVP A 500 (-3.7A) | 1.38A | 2jj8B-1osnA:13.4 | 2jj8B-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_B_AZZB1211_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ARG A 130PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 1.10A | 2jj8B-1osnA:13.4 | 2jj8B-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JJ8_B_AZZB1211_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | TRP A 53TYR A 66GLN A 90ARG A 130PHE A 139 | BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 0.98A | 2jj8B-1osnA:13.4 | 2jj8B-1osnA:23.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75TRP A 97LEU A 180GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.94A | 2kceA-4xscA:36.5 | 2kceA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.30A | 2kceA-4xscA:36.5 | 2kceA-4xscA:40.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2KCE_B_D16B568_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | LEU A 180ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.81A | 2kceB-4xscA:36.5 | 2kceB-4xscA:40.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KI5_A_AC2A1_1 (PROTEIN (THYMIDINEKINASE)) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53ILE A 65TYR A 66ARG A 143 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)None | 0.96A | 2ki5A-1osnA:34.4 | 2ki5A-1osnA:29.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KI5_A_AC2A1_1 (PROTEIN (THYMIDINEKINASE)) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 6 / 12 | TRP A 53ILE A 62ILE A 65TYR A 66GLN A 90ARG A 143 | BVP A 500 (-4.6A)BVP A 500 (-4.5A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)None | 0.71A | 2ki5A-1osnA:34.4 | 2ki5A-1osnA:29.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KI5_B_AC2B2_1 (PROTEIN (THYMIDINEKINASE)) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 48TRP A 53ILE A 65TYR A 66GLN A 90ARG A 130ARG A 143 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)None | 0.98A | 2ki5B-1osnA:35.1 | 2ki5B-1osnA:29.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KI5_B_AC2B2_1 (PROTEIN (THYMIDINEKINASE)) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 7 / 12 | TRP A 53ILE A 62ILE A 65TYR A 66GLN A 90ARG A 130ARG A 143 | BVP A 500 (-4.6A)BVP A 500 (-4.5A)BVP A 500 ( 4.2A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)None | 0.60A | 2ki5B-1osnA:35.1 | 2ki5B-1osnA:29.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_A_D16A309_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 7 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.28A | 2tsrA-4xscA:40.8 | 2tsrA-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 10 | PHE A 68GLU A 75ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.39A | 2tsrC-4xscA:40.5 | 2tsrC-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 10 | PHE A 68GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.60A | 2tsrC-4xscA:40.5 | 2tsrC-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 10 | PHE A 68GLU A 75ILE A 96TRP A 97PHE A 213TYR A 246 | None1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.77A | 2tsrC-4xscA:40.5 | 2tsrC-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 9 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.56A | 2tsrD-4xscA:24.4 | 2tsrD-4xscA:65.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 9 | PHE A 68ILE A 96TRP A 97PHE A 213TYR A 246 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.85A | 2tsrD-4xscA:24.4 | 2tsrD-4xscA:65.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_A_GEOA1210_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ALA A 134PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.9A)BVP A 500 (-3.7A) | 1.23A | 2vppA-1osnA:13.8 | 2vppA-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_A_GEOA1210_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ARG A 130PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 1.01A | 2vppA-1osnA:13.8 | 2vppA-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_A_GEOA1210_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | TRP A 53TYR A 66GLN A 90ARG A 130PHE A 139 | BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 0.93A | 2vppA-1osnA:13.8 | 2vppA-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_B_GEOB1207_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ALA A 134PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.9A)BVP A 500 (-3.7A) | 1.19A | 2vppB-1osnA:13.6 | 2vppB-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_B_GEOB1207_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ARG A 130PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 0.92A | 2vppB-1osnA:13.6 | 2vppB-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VPP_B_GEOB1207_1 (DEOXYNUCLEOSIDEKINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | TRP A 53TYR A 66GLN A 90ARG A 130PHE A 139 | BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 0.87A | 2vppB-1osnA:13.6 | 2vppB-1osnA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZI9_B_CL9B401_1 (DEOXYCYTIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66GLN A 90PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-3.7A) | 1.02A | 2zi9B-1osnA:15.7 | 2zi9B-1osnA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_A_CL9A401_1 (DEOXYCYTIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66GLN A 90PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-3.7A) | 0.94A | 2ziaA-1osnA:16.2 | 2ziaA-1osnA:22.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_A_CL9A401_1 (DEOXYCYTIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TYR A 66GLN A 90ARG A 130PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-2.8A)BVP A 500 (-3.7A) | 0.98A | 2ziaA-1osnA:16.2 | 2ziaA-1osnA:22.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_B_CL9B401_1 (DEOXYCYTIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66GLN A 90PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-3.7A) | 0.99A | 2ziaB-1osnA:15.8 | 2ziaB-1osnA:22.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3APV_B_TP0B190_1 (ALPHA-1-ACIDGLYCOPROTEIN 2) |
2w0s | THYMIDYLATE KINASE (Vacciniavirus) | 5 / 12 | LEU A 53GLU A 142ARG A 41SER A 97TYR A 101 | BVP A1207 ( 4.6A) MG A1206 (-4.3A)BVP A1207 (-3.7A)BVP A1207 ( 4.2A)BVP A1207 (-3.7A) | 1.40A | 3apvB-2w0sA:undetectable | 3apvB-2w0sA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 3 / 3 | SER A 91GLN A 90PHE A 93 | NoneBVP A 500 (-3.0A)BVP A 500 (-3.5A) | 0.83A | 3g4lC-1osnA:0.0 | 3g4lC-1osnA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HP1_A_LLTA401_1 (DEOXYCYTIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 48TRP A 53TYR A 66ALA A 134PHE A 139 | BVP A 500 (-2.5A)BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.9A)BVP A 500 (-3.7A) | 1.33A | 3hp1A-1osnA:16.0 | 3hp1A-1osnA:23.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HP1_A_LLTA401_1 (DEOXYCYTIDINE KINASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | TRP A 53TYR A 66GLN A 90ALA A 134PHE A 139 | BVP A 500 (-4.6A)BVP A 500 (-4.9A)BVP A 500 (-3.0A)BVP A 500 (-3.9A)BVP A 500 (-3.7A) | 1.31A | 3hp1A-1osnA:16.0 | 3hp1A-1osnA:23.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.82A | 3k2hA-4xscA:9.1 | 3k2hA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.94A | 3k2hA-4xscA:9.1 | 3k2hA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_A_LYAA513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180GLY A 210 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A) | 0.87A | 3k2hA-4xscA:9.1 | 3k2hA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.84A | 3k2hB-4xscA:8.6 | 3k2hB-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.95A | 3k2hB-4xscA:8.6 | 3k2hB-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K2H_B_LYAB513_1 (DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A) | 0.95A | 3k2hB-4xscA:8.6 | 3k2hB-4xscA:33.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NNE_A_ACTA601_0 (CHOLINE OXIDASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 5 | ILE A 215HIS A 238VAL A 200HIS A 184 | NoneNoneNoneBVP A1001 (-4.7A) | 1.44A | 3nneA-4xscA:undetectable | 3nneA-4xscA:20.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NNE_B_ACTB601_0 (CHOLINE OXIDASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 5 | ILE A 215HIS A 238VAL A 200HIS A 184 | NoneNoneNoneBVP A1001 (-4.7A) | 1.42A | 3nneB-4xscA:undetectable | 3nneB-4xscA:20.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ALA A 71ASP A 206GLY A 210PHE A 213TYR A 246 | NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.04A | 3nrrA-4xscA:11.5 | 3nrrA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96ASP A 206GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.64A | 3nrrA-4xscA:11.5 | 3nrrA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.10A | 3nrrA-4xscA:11.5 | 3nrrA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_A_D16A530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.68A | 3nrrA-4xscA:11.5 | 3nrrA-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ALA A 71ASP A 206GLY A 210PHE A 213TYR A 246 | NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.06A | 3nrrB-4xscA:11.4 | 3nrrB-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96ASP A 206GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.64A | 3nrrB-4xscA:11.4 | 3nrrB-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.11A | 3nrrB-4xscA:11.4 | 3nrrB-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NRR_B_D16B530_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.70A | 3nrrB-4xscA:11.4 | 3nrrB-4xscA:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180GLY A 210PHE A 213ASN A 214TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 1.26A | 3uwlB-4xscA:36.6 | 3uwlB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | ILE A 96LEU A 180HIS A 184LEU A 209GLY A 210ASN A 214TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-4.7A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 1.23A | 3uwlB-4xscA:36.6 | 3uwlB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_B_FOZB316_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.78A | 3uwlB-4xscA:36.6 | 3uwlB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214TYR A 246 | 1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.76A | 3uwlD-4xscA:34.5 | 3uwlD-4xscA:41.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WFH_B_P2EB301_1 (MAB FAB H FRAGMENTMAB FAB L FRAGMENT) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | PHE A 139VAL A 260TYR A 21HIS A 180LEU A 239 | BVP A 500 (-3.7A)NoneBVP A 500 ( 4.5A)NoneNone | 1.47A | 3wfhA-1osnA:undetectable3wfhB-1osnA:undetectable | 3wfhA-1osnA:20.183wfhB-1osnA:19.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WHX_B_XPGB301_1 (MAB FAB H FRAGMENTMAB FAB L FRAGMENT) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 5 / 12 | PHE A 139VAL A 260TYR A 21HIS A 180LEU A 239 | BVP A 500 (-3.7A)NoneBVP A 500 ( 4.5A)NoneNone | 1.47A | 3whxA-1osnA:undetectable3whxB-1osnA:undetectable | 3whxA-1osnA:20.473whxB-1osnA:19.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 12 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.65A | 4eb4A-4xscA:40.1 | 4eb4A-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | PHE A 68ILE A 96TRP A 97PHE A 213ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)1PE A1002 (-3.8A)BVP A1001 (-2.8A) | 0.70A | 4eb4A-4xscA:40.1 | 4eb4A-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 12 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.68A | 4eb4B-4xscA:40.1 | 4eb4B-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | PHE A 68ILE A 96TRP A 97PHE A 213ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)1PE A1002 (-3.8A)BVP A1001 (-2.8A) | 0.72A | 4eb4B-4xscA:40.1 | 4eb4B-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 9 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.63A | 4eb4C-4xscA:40.6 | 4eb4C-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 10 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.62A | 4eb4D-4xscA:40.5 | 4eb4D-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 10 | PHE A 68ILE A 96TRP A 97GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.74A | 4eb4D-4xscA:40.5 | 4eb4D-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.03A | 4fogA-4xscA:36.3 | 4fogA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96TRP A 97LEU A 180ASP A 206GLY A 210TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.74A | 4fogA-4xscA:36.3 | 4fogA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_C_C2FC302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | ILE A 96LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.12A | 4fogC-4xscA:36.4 | 4fogC-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_C_C2FC302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96TRP A 97LEU A 180ASP A 206GLY A 210TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.78A | 4fogC-4xscA:36.4 | 4fogC-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.12A | 4fogD-4xscA:36.4 | 4fogD-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.73A | 4fogD-4xscA:36.4 | 4fogD-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOG_D_C2FD302_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.71A | 4fogD-4xscA:36.4 | 4fogD-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96LEU A 180ASP A 206GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.75A | 4foxA-4xscA:36.4 | 4foxA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.83A | 4foxA-4xscA:36.4 | 4foxA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.14A | 4foxA-4xscA:36.4 | 4foxA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.77A | 4foxA-4xscA:36.4 | 4foxA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.20A | 4foxA-4xscA:36.4 | 4foxA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96LEU A 180ASP A 206GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.72A | 4foxB-4xscA:36.4 | 4foxB-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.77A | 4foxB-4xscA:36.4 | 4foxB-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.20A | 4foxB-4xscA:36.4 | 4foxB-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.80A | 4foxB-4xscA:36.4 | 4foxB-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | GLU A 75LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.82A | 4foxC-4xscA:36.3 | 4foxC-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | GLU A 75TRP A 97LEU A 180GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.85A | 4foxC-4xscA:36.3 | 4foxC-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.22A | 4foxC-4xscA:36.3 | 4foxC-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.23A | 4foxC-4xscA:36.3 | 4foxC-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.62A | 4foxD-4xscA:36.3 | 4foxD-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_D_D16D301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.99A | 4foxD-4xscA:36.3 | 4foxD-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.64A | 4foxE-4xscA:36.5 | 4foxE-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96TRP A 97GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.73A | 4foxE-4xscA:36.5 | 4foxE-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.08A | 4foxE-4xscA:36.5 | 4foxE-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_E_D16E301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96TRP A 97GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.22A | 4foxE-4xscA:36.5 | 4foxE-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | GLU A 75ILE A 96LEU A 180ASP A 206GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.85A | 4foxF-4xscA:36.4 | 4foxF-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | GLU A 75ILE A 96TRP A 97LEU A 180GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.89A | 4foxF-4xscA:36.4 | 4foxF-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.21A | 4foxF-4xscA:36.4 | 4foxF-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | ILE A 96TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.22A | 4foxF-4xscA:36.4 | 4foxF-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 75ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.74A | 4foxG-4xscA:36.5 | 4foxG-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.79A | 4foxG-4xscA:36.5 | 4foxG-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.17A | 4foxG-4xscA:36.5 | 4foxG-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.20A | 4foxG-4xscA:36.5 | 4foxG-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | GLU A 75ILE A 96ASP A 206GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.72A | 4foxH-4xscA:36.2 | 4foxH-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | GLU A 75ILE A 96TRP A 97GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.83A | 4foxH-4xscA:36.2 | 4foxH-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.97A | 4foxH-4xscA:36.2 | 4foxH-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FOX_H_D16H301_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | ILE A 96TRP A 97GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 1.18A | 4foxH-4xscA:36.2 | 4foxH-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.68A | 4fqsA-4xscA:36.3 | 4fqsA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_A_LYAA302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96TRP A 97LEU A 209GLY A 210 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)NoneBVP A1001 (-3.4A) | 0.71A | 4fqsA-4xscA:36.3 | 4fqsA-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.69A | 4fqsB-4xscA:36.3 | 4fqsB-4xscA:41.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FQS_B_LYAB302_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96TRP A 97LEU A 209GLY A 210 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)NoneBVP A1001 (-3.4A) | 0.70A | 4fqsB-4xscA:36.3 | 4fqsB-4xscA:41.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IAQ_A_2GMA2001_2 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 4 / 6 | TRP A 53ILE A 65THR A 86ASP A 18 | BVP A 500 (-4.6A)BVP A 500 ( 4.2A)NoneNone | 1.11A | 4iaqA-1osnA:1.0 | 4iaqA-1osnA:21.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 7 | ASP A 206LEU A 209GLY A 210TYR A 246 | NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.73A | 4iqqB-4xscA:38.6 | 4iqqB-4xscA:56.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 7 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.42A | 4iqqB-4xscA:38.6 | 4iqqB-4xscA:56.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IQQ_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 7 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.37A | 4iqqC-4xscA:38.8 | 4iqqC-4xscA:56.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XE3_A_CL6A502_1 (CYTOCHROME P-450) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 4 / 5 | LEU A 73ALA A 82THR A 86ILE A 65 | NoneNoneNoneBVP A 500 ( 4.2A) | 0.86A | 4xe3A-1osnA:undetectable | 4xe3A-1osnA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XE3_B_CL6B502_1 (CYTOCHROME P-450) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 4 / 5 | LEU A 73ALA A 82THR A 86ILE A 65 | NoneNoneNoneBVP A 500 ( 4.2A) | 0.92A | 4xe3B-1osnA:undetectable | 4xe3B-1osnA:22.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.65A | 5fctA-4xscA:40.5 | 5fctA-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | PHE A 68ILE A 96LEU A 180LEU A 209GLY A 210TYR A 246 | None1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.85A | 5fctA-4xscA:40.5 | 5fctA-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_A_C2FA402_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | PHE A 68ILE A 96TRP A 97LEU A 180GLY A 210 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A) | 0.85A | 5fctA-4xscA:40.5 | 5fctA-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | VAL A 67PHE A 68ILE A 96CYH A 183LEU A 209TYR A 246 | NoneNone1PE A1002 (-4.6A)BVP A1001 (-3.4A)NoneBVP A1001 (-4.5A) | 0.75A | 5fctB-4xscA:40.6 | 5fctB-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | VAL A 67PHE A 68ILE A 96LEU A 180LEU A 209TYR A 246 | NoneNone1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-4.5A) | 0.80A | 5fctB-4xscA:40.6 | 5fctB-4xscA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FCT_B_C2FB402_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | VAL A 67PHE A 68ILE A 96TRP A 97LEU A 180LEU A 209 | NoneNone1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)None | 0.81A | 5fctB-4xscA:40.6 | 5fctB-4xscA:65.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GLM_A_ACTA613_0 (GLYCOSIDE HYDROLASEFAMILY 43) |
2w0s | THYMIDYLATE KINASE (Vacciniavirus) | 3 / 3 | ASP A 13SER A 97TYR A 101 | MG A1206 ( 3.4A)BVP A1207 ( 4.2A)BVP A1207 (-3.7A) | 0.84A | 5glmA-2w0sA:undetectable | 5glmA-2w0sA:19.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_A_D16A401_1 (ORF70) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 7 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.40A | 5h3aA-4xscA:39.9 | 5h3aA-4xscA:57.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H3A_B_D16B401_1 (ORF70) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 7 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.44A | 5h3aB-4xscA:39.9 | 5h3aB-4xscA:57.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | GLU A 75ILE A 96LEU A 180LEU A 209GLY A 210 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A) | 0.60A | 5j7wC-4xscA:36.5 | 5j7wC-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 75ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.79A | 5j7wD-4xscA:36.5 | 5j7wD-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J7W_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180ASP A 206LEU A 209GLY A 210TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.88A | 5j7wD-4xscA:36.5 | 5j7wD-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 7 | ASP A 206LEU A 209GLY A 210TYR A 246 | NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.74A | 5nooA-4xscA:39.4 | 5nooA-4xscA:56.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_A_D16A402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 7 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.31A | 5nooA-4xscA:39.4 | 5nooA-4xscA:56.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 4 / 7 | ASP A 206LEU A 209GLY A 210TYR A 246 | NoneNoneBVP A1001 (-3.4A)BVP A1001 (-4.5A) | 0.74A | 5nooB-4xscA:39.2 | 5nooB-4xscA:56.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 7 | ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.37A | 5nooB-4xscA:39.2 | 5nooB-4xscA:56.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NOO_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 6 | ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.69A | 5nooC-4xscA:38.9 | 5nooC-4xscA:56.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OS7_A_ACTA402_0 (CASEIN KINASE IISUBUNIT ALPHA) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 3 / 3 | HIS A 244SER A 45LYS A 35 | BVP A1001 (-3.8A)NoneNone | 1.46A | 5os7A-4xscA:undetectable | 5os7A-4xscA:23.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TDZ_A_ADNA905_1 (ATP-CITRATE SYNTHASE) |
1osn | THYMIDINE KINASE (Humanalphaherpesvirus3) | 4 / 6 | ASP A 18ARG A 130LEU A 17ASP A 129 | NoneBVP A 500 (-2.8A)NoneBVP A 500 ( 4.9A) | 1.05A | 5tdzA-1osnA:undetectable | 5tdzA-1osnA:20.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | GLU A 75ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.62A | 5x5qB-4xscA:40.6 | 5x5qB-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_B_D16B402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | GLU A 75ILE A 96TRP A 97GLY A 210PHE A 213TYR A 246 | 1PE A1002 ( 4.4A)1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.78A | 5x5qB-4xscA:40.6 | 5x5qB-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 7 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.47A | 5x5qC-4xscA:41.0 | 5x5qC-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_D_D16D402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 8 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.47A | 5x5qD-4xscA:41.0 | 5x5qD-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X5Q_F_D16F402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 8 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.49A | 5x5qF-4xscA:41.5 | 5x5qF-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_A_MTXA402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 12 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.50A | 5x66A-4xscA:40.95x66B-4xscA:9.9 | 5x66A-4xscA:69.665x66B-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 9 | ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213ASN A 214TYR A 246 | 1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.39A | 5x66C-4xscA:40.9 | 5x66C-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_D_MTXD402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 10 | PHE A 68ILE A 96ASP A 206GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.47A | 5x66D-4xscA:41.2 | 5x66D-4xscA:69.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X66_F_MTXF402_1 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 12 | PHE A 68ILE A 96ASP A 206LEU A 209GLY A 210PHE A 213TYR A 246 | None1PE A1002 (-4.6A)NoneNoneBVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-4.5A) | 0.48A | 5x66F-4xscA:41.2 | 5x66F-4xscA:69.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GMD_B_ACTB402_0 (CASEIN KINASE IISUBUNIT ALPHA) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 3 / 3 | HIS A 244SER A 45LYS A 35 | BVP A1001 (-3.8A)NoneNone | 1.46A | 6gmdB-4xscA:undetectable | 6gmdB-4xscA:23.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180GLY A 210PHE A 213ASN A 214TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 1.29A | 6qxsB-4xscA:34.5 | 6qxsB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96LEU A 180LEU A 209GLY A 210ASN A 214TYR A 246 | 1PE A1002 (-4.6A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.82A | 6qxsB-4xscA:34.5 | 6qxsB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.66A | 6qxsB-4xscA:34.5 | 6qxsB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QXS_D_FOZD403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.55A | 6qxsD-4xscA:34.5 | 6qxsD-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_B_FOZB401_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A) | 0.55A | 6qyaB-4xscA:34.1 | 6qyaB-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | ILE A 96LEU A 209GLY A 210ASN A 214TYR A 246 | 1PE A1002 (-4.6A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.51A | 6qyaD-4xscA:34.1 | 6qyaD-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6QYA_D_FOZD401_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | 1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.59A | 6qyaD-4xscA:34.1 | 6qyaD-4xscA:41.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214TYR A 246 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 0.42A | 6r2eA-4xscA:40.0 | 6r2eA-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68ILE A 96GLY A 210PHE A 213ASN A 214TYR A 246 | None1PE A1002 (-4.6A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A)BVP A1001 (-4.5A) | 1.14A | 6r2eA-4xscA:40.0 | 6r2eA-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68ILE A 96LEU A 180GLY A 210PHE A 213ASN A 214 | None1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A) | 1.31A | 6r2eA-4xscA:40.0 | 6r2eA-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68ILE A 96TRP A 97LEU A 180GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.88A | 6r2eA-4xscA:40.0 | 6r2eA-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_A_FFOA403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.95A | 6r2eA-4xscA:40.0 | 6r2eA-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.39A | 6r2eB-4xscA:40.0 | 6r2eB-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_B_FFOB403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 10 | PHE A 68ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.94A | 6r2eB-4xscA:40.0 | 6r2eB-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.40A | 6r2eC-4xscA:39.9 | 6r2eC-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 10 | PHE A 68ILE A 96TRP A 97LEU A 180GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.88A | 6r2eC-4xscA:39.9 | 6r2eC-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_C_FFOC404_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 10 | PHE A 68TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.99A | 6r2eC-4xscA:39.9 | 6r2eC-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 10 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.40A | 6r2eD-4xscA:40.2 | 6r2eD-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_D_FFOD403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 10 | PHE A 68ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.87A | 6r2eD-4xscA:40.2 | 6r2eD-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 12 | PHE A 68ILE A 96LEU A 180GLY A 210PHE A 213ASN A 214 | None1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A) | 1.32A | 6r2eE-4xscA:39.7 | 6r2eE-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_E_FFOE403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 12 | PHE A 68ILE A 96TRP A 97TYR A 123LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)NoneBVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.92A | 6r2eE-4xscA:39.7 | 6r2eE-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.40A | 6r2eF-4xscA:39.9 | 6r2eF-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 11 | PHE A 68ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.89A | 6r2eF-4xscA:39.9 | 6r2eF-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 11 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.41A | 6r2eG-4xscA:39.7 | 6r2eG-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 6 / 11 | PHE A 68ILE A 96LEU A 180GLY A 210PHE A 213ASN A 214 | None1PE A1002 (-4.6A)BVP A1001 ( 4.5A)BVP A1001 (-3.4A)1PE A1002 (-3.8A)BVP A1001 (-2.8A) | 1.32A | 6r2eG-4xscA:39.7 | 6r2eG-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 7 / 11 | PHE A 68ILE A 96TRP A 97LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)BVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.94A | 6r2eG-4xscA:39.7 | 6r2eG-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 5 / 12 | PHE A 68ASP A 206LEU A 209GLY A 210ASN A 214 | NoneNoneNoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.41A | 6r2eH-4xscA:39.9 | 6r2eH-4xscA:65.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6R2E_H_FFOH403_0 (THYMIDYLATE SYNTHASE) |
4xsc | THYMIDYLATE SYNTHASE (Humanalphaherpesvirus3) | 8 / 12 | PHE A 68ILE A 96TRP A 97TYR A 123LEU A 180LEU A 209GLY A 210ASN A 214 | None1PE A1002 (-4.6A)1PE A1002 (-4.7A)NoneBVP A1001 ( 4.5A)NoneBVP A1001 (-3.4A)BVP A1001 (-2.8A) | 0.95A | 6r2eH-4xscA:39.9 | 6r2eH-4xscA:65.94 |